In vitro anti-cancer activities in Caco-2 and HCT-116 cells of recombinant cystatin C prepared by a Pichia expression system.
D000972:Antineoplastic Agents, Phytogenic / Q000378:metabolism* / Q000494:pharmacology; D018938:Caco-2 Cells; D002277:Carcinoma / Q000188:drug therapy / Q000201:enzymology*; D003110:Colonic Neoplasms / Q000188:drug therapy / Q000201:enzymology*; D055316:Cystatin C; D015891:Cystatins / Q000378:metabolism* / Q000494:pharmacology; D015853:Cysteine Proteinase Inhibitors / Q000378:metabolism* / Q000494:pharmacology; D045325:HCT116 Cells; D006801:Humans; D010843:Pichia / Q000235:genetics / Q000378:metabolism
D000972:Antineoplastic Agents, Phytogenic; C525030:CST3 protein, human; D055316:Cystatin C; D015891:Cystatins; D015853:Cysteine Proteinase Inhibitors